1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Non-Small Cell Lung Cancer Market
2.2. Global Non-Small Cell Lung Cancer Market, By Type, 2024 (US$ Million)
2.3. Global Non-Small Cell Lung Cancer Market, By Treatment, 2024 (US$ Million)
2.4. Global Non-Small Cell Lung Cancer Market, By Gender, 2024 (US$ Million)
2.5. Global Non-Small Cell Lung Cancer Market, By End Use, 2024 (US$ Million)
2.6. Global Non-Small Cell Lung Cancer Market, By Geography, 2024 (US$ Million)
2.7. Attractive Investment Proposition by Geography, 2024
3. Non-Small Cell Lung Cancer Market: Competitive Analysis
3.1. Market Positioning of Key Non-Small Cell Lung Cancer Market Vendors
3.2. Strategies Adopted by Non-Small Cell Lung Cancer Market Vendors
4. Non-Small Cell Lung Cancer Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Non-Small Cell Lung Cancer Market Value, 2023 - 2033, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. Porter's Five Force Model
4.5.1. Supplier Power
4.5.2. Buyer Power
4.5.3. Threat Of Substitutes
4.5.4. Threat Of New Entrants
4.5.5. Competitive Rivalry
4.6. PESTEL Analysis
4.6.1. Political Landscape
4.6.2. Economic Landscape
4.6.3. Technology Landscape
4.6.4. Legal Landscape
4.6.5. Social Landscape
5. Non-Small Cell Lung Cancer Market: By Type, 2023-2033, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2024 Versus 2033
5.3. Market Segmentation
5.3.1. Adenocarcinoma
5.3.2. Squamous cell carcinoma
5.3.3. Large cell carcinoma
5.3.4. Other types
6. Non-Small Cell Lung Cancer Market: By Treatment, 2023-2033, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2024 Versus 2033
6.3. Market Segmentation
6.3.1. Chemotherapy
6.3.2. Immunotherapy
6.3.3. Targeted therapy
6.3.4. Other treatment types
7. Non-Small Cell Lung Cancer Market: By Gender, 2023-2033, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2024 Versus 2033
7.3. Market Segmentation
7.3.1. Male
7.3.2. Female
8. Non-Small Cell Lung Cancer Market: By End Use, 2023-2033, USD (Million)
8.1. Market Overview
8.2. Growth & Revenue Analysis: 2024 Versus 2033
8.3. Market Segmentation
8.3.1. Hospitals
8.3.2. Specialty clinics
8.3.3. Other end use
9. North America Non-Small Cell Lung Cancer Market, 2023-2033, USD (Million)
9.1. Market Overview
9.2. Non-Small Cell Lung Cancer Market: By Type, 2023-2033, USD (Million)
9.3. Non-Small Cell Lung Cancer Market: By Treatment, 2023-2033, USD (Million)
9.4. Non-Small Cell Lung Cancer Market: By Gender, 2023-2033, USD (Million)
9.5. Non-Small Cell Lung Cancer Market: By End Use, 2023-2033, USD (Million)
9.6.Non-Small Cell Lung Cancer Market: By Region, 2023-2033, USD (Million)
9.6.1.North America
9.6.1.1. U.S.
9.6.1.1.1. Non-Small Cell Lung Cancer Market: By Type, 2023-2033, USD (Million)
9.6.1.1.2. Non-Small Cell Lung Cancer Market: By Treatment, 2023-2033, USD (Million)
9.6.1.1.3. Non-Small Cell Lung Cancer Market: By Gender, 2023-2033, USD (Million)
9.6.1.1.4. Non-Small Cell Lung Cancer Market: By End Use, 2023-2033, USD (Million)
9.6.1.2. Canada
9.6.1.2.1. Non-Small Cell Lung Cancer Market: By Type, 2023-2033, USD (Million)
9.6.1.2.2. Non-Small Cell Lung Cancer Market: By Treatment, 2023-2033, USD (Million)
9.6.1.2.3. Non-Small Cell Lung Cancer Market: By Gender, 2023-2033, USD (Million)
9.6.1.2.4. Non-Small Cell Lung Cancer Market: By End Use, 2023-2033, USD (Million)
9.6.1.3. Rest of North America
9.6.1.3.1. Non-Small Cell Lung Cancer Market: By Type, 2023-2033, USD (Million)
9.6.1.3.2. Non-Small Cell Lung Cancer Market: By Treatment, 2023-2033, USD (Million)
9.6.1.3.3. Non-Small Cell Lung Cancer Market: By Gender, 2023-2033, USD (Million)
9.6.1.3.4. Non-Small Cell Lung Cancer Market: By End Use, 2023-2033, USD (Million)
10. UK and European Union Non-Small Cell Lung Cancer Market, 2023-2033, USD (Million)
10.1. Market Overview
10.2. Non-Small Cell Lung Cancer Market: By Type, 2023-2033, USD (Million)
10.3. Non-Small Cell Lung Cancer Market: By Treatment, 2023-2033, USD (Million)
10.4. Non-Small Cell Lung Cancer Market: By Gender, 2023-2033, USD (Million)
10.5. Non-Small Cell Lung Cancer Market: By End Use, 2023-2033, USD (Million)
10.6.Non-Small Cell Lung Cancer Market: By Region, 2023-2033, USD (Million)
10.6.1.UK and European Union
10.6.1.1. UK
10.6.1.1.1. Non-Small Cell Lung Cancer Market: By Type, 2023-2033, USD (Million)
10.6.1.1.2. Non-Small Cell Lung Cancer Market: By Treatment, 2023-2033, USD (Million)
10.6.1.1.3. Non-Small Cell Lung Cancer Market: By Gender, 2023-2033, USD (Million)
10.6.1.1.4. Non-Small Cell Lung Cancer Market: By End Use, 2023-2033, USD (Million)
10.6.1.2. Germany
10.6.1.2.1. Non-Small Cell Lung Cancer Market: By Type, 2023-2033, USD (Million)
10.6.1.2.2. Non-Small Cell Lung Cancer Market: By Treatment, 2023-2033, USD (Million)
10.6.1.2.3. Non-Small Cell Lung Cancer Market: By Gender, 2023-2033, USD (Million)
10.6.1.2.4. Non-Small Cell Lung Cancer Market: By End Use, 2023-2033, USD (Million)
10.6.1.3. Spain
10.6.1.3.1. Non-Small Cell Lung Cancer Market: By Type, 2023-2033, USD (Million)
10.6.1.3.2. Non-Small Cell Lung Cancer Market: By Treatment, 2023-2033, USD (Million)
10.6.1.3.3. Non-Small Cell Lung Cancer Market: By Gender, 2023-2033, USD (Million)
10.6.1.3.4. Non-Small Cell Lung Cancer Market: By End Use, 2023-2033, USD (Million)
10.6.1.4. Italy
10.6.1.4.1. Non-Small Cell Lung Cancer Market: By Type, 2023-2033, USD (Million)
10.6.1.4.2. Non-Small Cell Lung Cancer Market: By Treatment, 2023-2033, USD (Million)
10.6.1.4.3. Non-Small Cell Lung Cancer Market: By Gender, 2023-2033, USD (Million)
10.6.1.4.4. Non-Small Cell Lung Cancer Market: By End Use, 2023-2033, USD (Million)
10.6.1.5. France
10.6.1.5.1. Non-Small Cell Lung Cancer Market: By Type, 2023-2033, USD (Million)
10.6.1.5.2. Non-Small Cell Lung Cancer Market: By Treatment, 2023-2033, USD (Million)
10.6.1.5.3. Non-Small Cell Lung Cancer Market: By Gender, 2023-2033, USD (Million)
10.6.1.5.4. Non-Small Cell Lung Cancer Market: By End Use, 2023-2033, USD (Million)
10.6.1.6. Rest of Europe
10.6.1.6.1. Non-Small Cell Lung Cancer Market: By Type, 2023-2033, USD (Million)
10.6.1.6.2. Non-Small Cell Lung Cancer Market: By Treatment, 2023-2033, USD (Million)
10.6.1.6.3. Non-Small Cell Lung Cancer Market: By Gender, 2023-2033, USD (Million)
10.6.1.6.4. Non-Small Cell Lung Cancer Market: By End Use, 2023-2033, USD (Million)
11. Asia Pacific Non-Small Cell Lung Cancer Market, 2023-2033, USD (Million)
11.1. Market Overview
11.2. Non-Small Cell Lung Cancer Market: By Type, 2023-2033, USD (Million)
11.3. Non-Small Cell Lung Cancer Market: By Treatment, 2023-2033, USD (Million)
11.4. Non-Small Cell Lung Cancer Market: By Gender, 2023-2033, USD (Million)
11.5. Non-Small Cell Lung Cancer Market: By End Use, 2023-2033, USD (Million)
11.6.Non-Small Cell Lung Cancer Market: By Region, 2023-2033, USD (Million)
11.6.1.Asia Pacific
11.6.1.1. China
11.6.1.1.1. Non-Small Cell Lung Cancer Market: By Type, 2023-2033, USD (Million)
11.6.1.1.2. Non-Small Cell Lung Cancer Market: By Treatment, 2023-2033, USD (Million)
11.6.1.1.3. Non-Small Cell Lung Cancer Market: By Gender, 2023-2033, USD (Million)
11.6.1.1.4. Non-Small Cell Lung Cancer Market: By End Use, 2023-2033, USD (Million)
11.6.1.2. Japan
11.6.1.2.1. Non-Small Cell Lung Cancer Market: By Type, 2023-2033, USD (Million)
11.6.1.2.2. Non-Small Cell Lung Cancer Market: By Treatment, 2023-2033, USD (Million)
11.6.1.2.3. Non-Small Cell Lung Cancer Market: By Gender, 2023-2033, USD (Million)
11.6.1.2.4. Non-Small Cell Lung Cancer Market: By End Use, 2023-2033, USD (Million)
11.6.1.3. India
11.6.1.3.1. Non-Small Cell Lung Cancer Market: By Type, 2023-2033, USD (Million)
11.6.1.3.2. Non-Small Cell Lung Cancer Market: By Treatment, 2023-2033, USD (Million)
11.6.1.3.3. Non-Small Cell Lung Cancer Market: By Gender, 2023-2033, USD (Million)
11.6.1.3.4. Non-Small Cell Lung Cancer Market: By End Use, 2023-2033, USD (Million)
11.6.1.4. Australia
11.6.1.4.1. Non-Small Cell Lung Cancer Market: By Type, 2023-2033, USD (Million)
11.6.1.4.2. Non-Small Cell Lung Cancer Market: By Treatment, 2023-2033, USD (Million)
11.6.1.4.3. Non-Small Cell Lung Cancer Market: By Gender, 2023-2033, USD (Million)
11.6.1.4.4. Non-Small Cell Lung Cancer Market: By End Use, 2023-2033, USD (Million)
11.6.1.5. South Korea
11.6.1.5.1. Non-Small Cell Lung Cancer Market: By Type, 2023-2033, USD (Million)
11.6.1.5.2. Non-Small Cell Lung Cancer Market: By Treatment, 2023-2033, USD (Million)
11.6.1.5.3. Non-Small Cell Lung Cancer Market: By Gender, 2023-2033, USD (Million)
11.6.1.5.4. Non-Small Cell Lung Cancer Market: By End Use, 2023-2033, USD (Million)
11.6.1.6. Rest of Asia Pacific
11.6.1.6.1. Non-Small Cell Lung Cancer Market: By Type, 2023-2033, USD (Million)
11.6.1.6.2. Non-Small Cell Lung Cancer Market: By Treatment, 2023-2033, USD (Million)
11.6.1.6.3. Non-Small Cell Lung Cancer Market: By Gender, 2023-2033, USD (Million)
11.6.1.6.4. Non-Small Cell Lung Cancer Market: By End Use, 2023-2033, USD (Million)
12. Latin America Non-Small Cell Lung Cancer Market, 2023-2033, USD (Million)
12.1. Market Overview
12.2. Non-Small Cell Lung Cancer Market: By Type, 2023-2033, USD (Million)
12.3. Non-Small Cell Lung Cancer Market: By Treatment, 2023-2033, USD (Million)
12.4. Non-Small Cell Lung Cancer Market: By Gender, 2023-2033, USD (Million)
12.5. Non-Small Cell Lung Cancer Market: By End Use, 2023-2033, USD (Million)
12.6.Non-Small Cell Lung Cancer Market: By Region, 2023-2033, USD (Million)
12.6.1.Latin America
12.6.1.1. Brazil
12.6.1.1.1. Non-Small Cell Lung Cancer Market: By Type, 2023-2033, USD (Million)
12.6.1.1.2. Non-Small Cell Lung Cancer Market: By Treatment, 2023-2033, USD (Million)
12.6.1.1.3. Non-Small Cell Lung Cancer Market: By Gender, 2023-2033, USD (Million)
12.6.1.1.4. Non-Small Cell Lung Cancer Market: By End Use, 2023-2033, USD (Million)
12.6.1.2. Mexico
12.6.1.2.1. Non-Small Cell Lung Cancer Market: By Type, 2023-2033, USD (Million)
12.6.1.2.2. Non-Small Cell Lung Cancer Market: By Treatment, 2023-2033, USD (Million)
12.6.1.2.3. Non-Small Cell Lung Cancer Market: By Gender, 2023-2033, USD (Million)
12.6.1.2.4. Non-Small Cell Lung Cancer Market: By End Use, 2023-2033, USD (Million)
12.6.1.3. Rest of Latin America
12.6.1.3.1. Non-Small Cell Lung Cancer Market: By Type, 2023-2033, USD (Million)
12.6.1.3.2. Non-Small Cell Lung Cancer Market: By Treatment, 2023-2033, USD (Million)
12.6.1.3.3. Non-Small Cell Lung Cancer Market: By Gender, 2023-2033, USD (Million)
12.6.1.3.4. Non-Small Cell Lung Cancer Market: By End Use, 2023-2033, USD (Million)
13. Middle East and Africa Non-Small Cell Lung Cancer Market, 2023-2033, USD (Million)
13.1. Market Overview
13.2. Non-Small Cell Lung Cancer Market: By Type, 2023-2033, USD (Million)
13.3. Non-Small Cell Lung Cancer Market: By Treatment, 2023-2033, USD (Million)
13.4. Non-Small Cell Lung Cancer Market: By Gender, 2023-2033, USD (Million)
13.5. Non-Small Cell Lung Cancer Market: By End Use, 2023-2033, USD (Million)
13.6.Non-Small Cell Lung Cancer Market: By Region, 2023-2033, USD (Million)
13.6.1.Middle East and Africa
13.6.1.1. GCC
13.6.1.1.1. Non-Small Cell Lung Cancer Market: By Type, 2023-2033, USD (Million)
13.6.1.1.2. Non-Small Cell Lung Cancer Market: By Treatment, 2023-2033, USD (Million)
13.6.1.1.3. Non-Small Cell Lung Cancer Market: By Gender, 2023-2033, USD (Million)
13.6.1.1.4. Non-Small Cell Lung Cancer Market: By End Use, 2023-2033, USD (Million)
13.6.1.2. Africa
13.6.1.2.1. Non-Small Cell Lung Cancer Market: By Type, 2023-2033, USD (Million)
13.6.1.2.2. Non-Small Cell Lung Cancer Market: By Treatment, 2023-2033, USD (Million)
13.6.1.2.3. Non-Small Cell Lung Cancer Market: By Gender, 2023-2033, USD (Million)
13.6.1.2.4. Non-Small Cell Lung Cancer Market: By End Use, 2023-2033, USD (Million)
13.6.1.3. Rest of Middle East and Africa
13.6.1.3.1. Non-Small Cell Lung Cancer Market: By Type, 2023-2033, USD (Million)
13.6.1.3.2. Non-Small Cell Lung Cancer Market: By Treatment, 2023-2033, USD (Million)
13.6.1.3.3. Non-Small Cell Lung Cancer Market: By Gender, 2023-2033, USD (Million)
13.6.1.3.4. Non-Small Cell Lung Cancer Market: By End Use, 2023-2033, USD (Million)
14. Company Profile
14.1. Astellas Pharma
(Company Overview, Financial Performance, Product Portfolio, Strategic Initiatives)
14.2. AstraZeneca
14.3. Eli Lilly
14.4. F. Hoffmann La Roche
14.5. Janssen Biotech
14.6. Merck & Co.
14.7. Novartis
14.8. Pfizer
14.9. Sanofi
14.10. Sun Pharmaceutical
14.11. Other Notable Players
